Pharmalot… Pharmalittle… Good Morning
1 CommentBy Ed Silverman // May 17th, 2010 // 6:55 am
• Pharma Blog » Archives
Biogenerics
Specialty Drugs, Medicare D & Catastrophic Coverage
5 CommentsBy Ed Silverman // March 2nd, 2010 // 7:59 am
An 11th-Hour Battle Over Biogenerics In Congress
3 CommentsBy Ed Silverman // January 14th, 2010 // 8:44 pm
Merck Wants To Develop Follow-On Biologics
2 CommentsBy Ed Silverman // December 9th, 2008 // 10:11 am
FTC Holds Roundtable On Follow-On Biologics
4 CommentsBy Ed Silverman // November 21st, 2008 // 7:22 am
Specialty Med Prices Greatly Outstrip Inflation
1 CommentBy Ed Silverman // September 25th, 2008 // 1:07 pm
Obama & McCain Agree On One Thing: Generics
Make a commentBy Ed Silverman // September 18th, 2008 // 1:36 pm
FTC Reviewing Follow-On Biologics And Competition
Make a commentBy Ed Silverman // August 28th, 2008 // 4:38 pm
Insmed Develops Biologic For Amgen’s Neupogen
2 CommentsBy Ed Silverman // July 10th, 2008 // 9:02 am